These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 27009858)

  • 1. Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress.
    Dai Y; Wang L; Tang J; Cao P; Luo Z; Sun J; Kiflu A; Sai B; Zhang M; Wang F; Li G; Xiang J
    Oncotarget; 2016 May; 7(18):25478-92. PubMed ID: 27009858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
    Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
    Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRRX1 Regulates Cellular Phenotype Plasticity and Dormancy of Head and Neck Squamous Cell Carcinoma Through miR-642b-3p.
    Jiang J; Zheng M; Zhang M; Yang X; Li L; Wang SS; Wu JS; Yu XH; Wu JB; Pang X; Tang YJ; Tang YL; Liang XH
    Neoplasia; 2019 Feb; 21(2):216-229. PubMed ID: 30622052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral Heterogeneity in EGFR-Mutant NSCLC Results in Divergent Resistance Mechanisms in Response to EGFR Tyrosine Kinase Inhibition.
    Soucheray M; Capelletti M; Pulido I; Kuang Y; Paweletz CP; Becker JH; Kikuchi E; Xu C; Patel TB; Al-Shahrour F; Carretero J; Wong KK; Jänne PA; Shapiro GI; Shimamura T
    Cancer Res; 2015 Oct; 75(20):4372-83. PubMed ID: 26282169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
    Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
    Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
    Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
    Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer.
    Rastogi I; Rajanna S; Webb A; Chhabra G; Foster B; Webb B; Puri N
    Biochem Biophys Res Commun; 2016 Sep; 477(4):937-944. PubMed ID: 27396618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular dormancy in minimal residual disease following targeted therapy.
    Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
    Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycorine possesses notable anticancer potentials in on-small cell lung carcinoma cells via blocking Wnt/β-catenin signaling and epithelial-mesenchymal transition (EMT).
    Sun Y; Wu P; Sun Y; Sharopov FS; Yang Q; Chen F; Wang P; Liang Z
    Biochem Biophys Res Commun; 2018 Jan; 495(1):911-921. PubMed ID: 29127013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest.
    Kriegs M; Gurtner K; Can Y; Brammer I; Rieckmann T; Oertel R; Wysocki M; Dorniok F; Gal A; Grob TJ; Laban S; Kasten-Pisula U; Petersen C; Baumann M; Krause M; Dikomey E
    Radiother Oncol; 2015 Apr; 115(1):120-7. PubMed ID: 25796091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer.
    Wang Y; Han T; Gan M; Guo M; Xie C; Jin J; Zhang S; Wang P; Cao J; Wang JB
    Cell Cycle; 2019 May; 18(9):1019-1032. PubMed ID: 31023143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis.
    Zhang N; Liu Y; Wang Y; Zhao M; Tu L; Luo F
    Drug Des Devel Ther; 2017; 11():969-983. PubMed ID: 28405157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
    Zhang Y; Zhang Q; Chen H; Wang C
    Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.
    Deneka AY; Haber L; Kopp MC; Gaponova AV; Nikonova AS; Golemis EA
    PLoS One; 2017; 12(4):e0176747. PubMed ID: 28453558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
    Da C; Liu Y; Zhan Y; Liu K; Wang R
    Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies.
    Heilman DW; Teodoro JG; Green MR
    J Virol; 2006 Aug; 80(15):7535-45. PubMed ID: 16840333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin beta 1 enhances the epithelial-mesenchymal transition in association with gefitinib resistance of non-small cell lung cancer.
    Ju L; Zhou C
    Cancer Biomark; 2013; 13(5):329-36. PubMed ID: 24440972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.